GeoVax Labs (GOVX) VP receives grant of 17,600 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
GeoVax Labs, Inc. granted stock options to a senior executive. VP of Business Development John W. Sharkey received an award of 17,600 stock options for common stock on June 17, 2026 at an exercise price of $1.18 per share.
The options vest in three equal annual installments on the first three anniversaries of the grant date and expire on June 17, 2036. This is a compensation-related grant, not an open-market purchase or sale, and leaves Sharkey holding 17,600 options directly after the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Sharkey John W.
Role
VP, Business Development
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 17,600 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 17,600 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 17,600 options
Exercise price: $1.18 per share
Expiration date: June 17, 2036
+1 more
4 metrics
Options granted
17,600 options
Stock option award to VP on June 17, 2026
Exercise price
$1.18 per share
Conversion or exercise price of granted options
Expiration date
June 17, 2036
Option term for this grant
Post-grant holdings
17,600 options
Total options held directly following this transaction
Key Terms
Stock Option, grant/award acquisition, exercise price, expiration date, +1 more
5 terms
Stock Option financial
"Stock Option becomes exercisable in three equal annual installments"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
grant/award acquisition financial
"transaction_action: grant/award acquisition for 17,600 options"
exercise price financial
"conversion_or_exercise_price of $1.18 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date set to June 17, 2036 for the options"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"becomes exercisable in three equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did GeoVax Labs (GOVX) report in this Form 4 filing?
GeoVax Labs reported that VP of Business Development John W. Sharkey received a grant of 17,600 stock options. These options are for GeoVax common stock, have an exercise price of $1.18 per share, and represent a compensation-related award, not a market trade.
How many GeoVax (GOVX) stock options were granted to John W. Sharkey?
John W. Sharkey was granted 17,600 stock options for GeoVax common stock. All 17,600 options are held directly after the transaction, giving him the right to buy the same number of shares if he chooses to exercise at the stated price.
What is the exercise price and expiration date of the new GeoVax options?
The new GeoVax stock options have an exercise price of $1.18 per share and expire on June 17, 2036. This means Sharkey can choose to buy shares at $1.18 any time before that expiration, subject to the vesting schedule.
How do the GeoVax (GOVX) options granted to Sharkey vest over time?
The stock options vest in three equal annual installments on the first three anniversaries of the June 17, 2026 grant date. This staggered vesting encourages longer-term alignment, as Sharkey must remain over time to gain full access to all granted options.